An Application of the Cure Model to a Cardiovascular Clinical Trial

Varadan Sevilimedu (), Shuangge Ma, Pamela Hartigan and Tassos C. Kyriakides
Additional contact information
Varadan Sevilimedu: Memorial Sloan Kettering Cancer Center
Shuangge Ma: Yale University School of Public Health
Pamela Hartigan: Coordinative Studies Program
Tassos C. Kyriakides: Coordinative Studies Program

Statistics in Biosciences, 2021, vol. 13, issue 3, No 3, 402-430

Abstract: Abstract Intermediate events play an important role in determining the risk of a medical condition over time and should thus be accounted for in survival analysis. Myocardial infarction (MI) is one such condition whose hazard also depends upon the possible occurrence of an intermediate event—acute coronary syndrome (ACS). Accounting for the role that a possible ACS event plays in altering the hazard of MI becomes complicated when there is a cured fraction in the population. Data from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial presents the scenario where the existence of a cured fraction is highly likely. In this article, we model the risk of developing an MI, while properly accounting for the effect/impact of a probable intermediate ACS event on that risk in the presence of a cured fraction. We adapt a maximum likelihood estimation approach to estimate the regression coefficients of this multi-part cure model. Simulation demonstrates satisfactory performance of the proposed estimator. We also utilize this dataset to explore the use of a proportionality constraint to help reduce the dimensionality of this multi-part model. The analysis yields novel findings that can be useful in guiding clinical practice.

Keywords: Intermediate event; Cure model; Proportionality (search for similar items in EconPapers)
Date: 2021
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s12561-020-09297-w Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:stabio:v:13:y:2021:i:3:d:10.1007_s12561-020-09297-w

Ordering information: This journal article can be ordered from
http://www.springer.com/journal/12561

DOI: 10.1007/s12561-020-09297-w

Access Statistics for this article

Statistics in Biosciences is currently edited by Hongyu Zhao and Xihong Lin

More articles in Statistics in Biosciences from Springer, International Chinese Statistical Association
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().